Galmed Pharmaceuticals (GLMD) Asset Utilization Ratio (2017 - 2019)
Galmed Pharmaceuticals (GLMD) posted quarterly Asset Utilization Ratio of 0.02 for Q2 2019, up 4.84% year-over-year from 0.02 in Q2 2018, and down 7.86% quarter-over-quarter from 0.02 in Q4 2018.
Galmed Pharmaceuticals (GLMD) Asset Utilization Ratio (2017 - 2019) Analysis & Trends
Galmed Pharmaceuticals' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.02 for Q2 2019.
- In Q2 2019, Asset Utilization Ratio rose 4.84% year-over-year to 0.02; the TTM figure through Jun 2019 stood at 0.02 (up 4.84% YoY), while the FY2018 annual figure was 0.04, down 38.5% from the prior year.
- Asset Utilization Ratio for Q2 2019 stood at 0.02, down from 0.02 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.11 in Q3 2017, with the low at 0.02 in Q2 2018.
- The 3-year median for Asset Utilization Ratio is 0.05 (2017), against an average of 0.05.
- Peak annual rise in Asset Utilization Ratio reached 19.53% in 2018, while the deepest fall reached 77.97% in 2018.
- Galmed Pharmaceuticals' Asset Utilization Ratio stood at 0.07 in 2017, then slumped by 69.99% to 0.02 in 2018, then decreased by 7.86% to 0.02 in 2019.
- Business Quant data shows GLMD's Asset Utilization Ratio at 0.02 in Q2 2019, 0.02 in Q4 2018, and 0.02 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Galmed Pharmaceuticals | 2.31 Mn | -9.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 0.02 |
| Dec 31, 2018 | 0.02 |
| Sep 30, 2018 | 0.02 |
| Jun 30, 2018 | 0.02 |
| Mar 31, 2018 | 0.06 |
| Dec 31, 2017 | 0.07 |
| Sep 30, 2017 | 0.11 |
| Jun 30, 2017 | 0.09 |
| Mar 31, 2017 | 0.05 |